SCHEMBL18230312

SCHEMBL18230312

O=C(Nc1nc(-c2ccccn2)c(C(F)(F)F)s1)c1cccc(Oc2ccc(F)cc2)c1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GCK P35557 6/20 0.55
▸ GRM1 Q13255 1/20 0.49
▸ TRPV4 Q9HBA0 1/20 0.45
▸ ADORA2A P29274 1/20 0.45
▸ ADORA1 P30542 1/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ DHODH Q02127 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ ADORA3 P0DMS8 2/20 0.43
▸ SCD O00767 1/20 0.42
▸ LOX P28300 1/20 0.42
▸ LOXL2 Q9Y4K0 1/20 0.42
▸ MITF O75030 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18230228 0.94 GCK (0.52) GCKTRPV4ADORA2AADORA1MEN1
SCHEMBL18230222 0.93 ADORA2A (0.48) GCKGRM1TRPV4ADORA2AADORA1
SCHEMBL18230402 0.88 ADORA1 (0.55) GRM1TRPV4ADORA2AADORA1MEN1
SCHEMBL18230522 0.87 PCSK9 (0.50) TRPV4ADORA2AADORA1MEN1NPC1
SCHEMBL18230382 0.85 TRPV1 (0.53) GRM1TRPV4ADORA2AADORA1MEN1
SCHEMBL18230491 0.85 GRM1 (0.47) GCKGRM1TRPV4ADORA2AADORA1
SCHEMBL18230324 0.82 TLR7 (0.54) ADORA2AADORA1DHODHADORA3
SCHEMBL18230427 0.81 ADORA1 (0.54) GRM1TRPV4ADORA2AADORA1ADORA3
SCHEMBL18094583 0.81 GCK (0.58) GCKGRM1ADORA3LOXLOXL2
SCHEMBL18230261 0.81 ADORA3 (0.62) TRPV4ADORA2AADORA1MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016183173-A1 ANTIPARASITIC COMPOUNDS Avista Pharma Solutions (US) 2016-11-17 — — WO disclosed
WO-2016183173-A1 ANTIPARASITIC COMPOUNDS Avista Pharma Solutions (US) 2016-11-17 — — WO disclosed
Send feedback